GSK Extends Tender Offer To Acquire Human Genome Sciences For $13.00/Shr In Cash

GSK Reports Regulatory Submission For Umeclidinium Monotherapy In U.S.

GlaxoSmithKline Q1 Profit Declines, Backs Full Year Goals

GlaxoSmithKline Q1 Profit Slides - Quick Facts

GSK, Theravance Submits Regulatory Application For UMEC/VI In Japan

Trade GSK now with

6/8/2012 8:50 AM ET

GlaxoSmithKline Plc (GSK: Quote,GSK.L) said it has extended its tender offer to buy all of the outstanding shares of Human Genome Sciences (HGSI: Quote) for $13.00 per share in cash to 5:00 p.m. New York City time on June 29, 2012.

The tender offer was earlier scheduled to expire at 12:00 midnight New York City time, at the end of the day on June 7, 2012.

GSK's offer represents a premium of 81 percent to Human Genome Sciences' closing share price of $7.17 on April 18, 2012, the last trading day before Human Genome Sciences publicly disclosed GSK's private offer. GSK continues to believe its offer represents full and fair value and is in the best interests of both companies' shareholders.

Click here to receive FREE breaking news email alerts for GlaxoSmithKline PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 123 Articles

Editors Pick

HP Profit Falls Yet Tops Estimates

Hewlett-Packard Co. said Wednesday after the markets closed that its second quarter profit fell 32% from last year, hurt by lower revenue and weaker margins amid a slump in PC sales. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast.

Worries About Fed Tapering Lead To Sell-Off On Wall Street - U.S. Commentary

Stocks showed a substantial downturn over the course of the trading day on Wednesday after seeing some strength in morning trading. Renewed worries about the Federal Reserve tapering its asset purchase program contributed to the sharp pullback by the markets. The major averages climbed off their worst levels going into the close but still ended the day firmly negative.

Fed Minutes Show Some Members Want To Scale Back QE3 This Summer

Some members of the Federal Reserve favor scaling back the central bank's $85 billion a month asset purchase program this summer as long as the economy continues to improve, according the the minutes of the Fed's April 30-May 1 meeting. "A number of participants expressed willingness to adjust the...